Study ID: COG ACNS0334
Description:

A Phase III randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by consolidation with Stem Cell Rescue vs. The Same Therapy Without Methotrexate

Location:
Sioux Falls Region
Principal Investigator:
Kayelyn Wagner MD
Disease:
CNS (Brain Tumors)
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list